Literature DB >> 20379122

Changes in characteristics of Alzheimer patients at first visit to centers for dementia: a 10-year follow-up study.

Luca Rozzini1, Barbara Vicini Chilovi, Maddalena Riva, Renzo Rozzini, Stefano Boffelli, Marco Trabucchi, Alessandro Padovani.   

Abstract

BACKGROUND AND AIMS: The Cronos Project is an observational study on Alzheimer's disease (AD), created by Italy's Ministry of Public Health in 2000. The aim of our study was to evaluate whether the clinical characteristics of patients at their first visit to the Alzheimer Evaluation Unit (UVA) changed from September 2000 to December 2009, and to examine possible reasons for changes noted.
METHODS: 1532 consecutive patients were enrolled in two UVAs (September 2000 to December 2009) in a retrospective, descriptive study, with medical records as the primary source of data.
RESULTS: Patients' age at the first visit was not different throughout the period of observation. No differences were observed with regard to education or functional characteristics. However, a reduction in the severity of cognitive impairment was found during the period of evaluation: patients consecutively recruited in the first years were more cognitively, functionally, and psycho- behaviorally compromised than patients recruited in the following years.
CONCLUSIONS: Data show changes in characteristics at the first visit in patients affected by cognitive deterioration during the years of observation. This finding indicates new clinical needs of patients, requiring changes in pharmacological treatment and in general of the clinical approach.

Entities:  

Mesh:

Year:  2010        PMID: 20379122     DOI: 10.3275/6969

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  1 in total

1.  The Italian Version of the Five-Word Test: A Simple Diagnostic Test for Dementia due to Alzheimer's Disease in Routine Clinical Practice.

Authors:  Luca Rozzini; Anna Ceraso; Marina Zanetti; Silvia Pelizzari; Evita Tomasoni; Vivian Accardo; Alessandro Padovani
Journal:  Behav Neurol       Date:  2017-09-25       Impact factor: 3.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.